Ticlopidine hydrochloride use and threatened stroke.
Ticlopidine hydrochloride is an antiplatelet agent of proven antithrombotic efficacy that in December 1991 became available for general clinical use in the United States. The relative value of ticlopidine compared with aspirin, also an effective antiplatelet agent, has become a key clinical issue. W...
Na minha lista:
| Publicado no: | West J Med |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1994
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1022253/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8128701/ |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
